New Issue: Alexion prices $129 million of stock at $43, discounted from $43.35

New York, Nov. 15 - Alexion Pharmaceuticals, Inc. priced a $129 million offering of common stock at $43.00 per share, slightly discounted from the closing level of $43.35.

The Cheshire, Conn., biotechnology company sold 3 million shares after the close Wednesday. There is a greenshoe for a further 450,000 shares.

Goldman, Sachs & Co. and Morgan Stanley & Co. Inc. were bookrunners with Bear, Stearns & Co. Inc., Credit Suisse, Cowen and Co., LLC and Piper Jaffray & Co. as co-managers.

Issuer:	Alexion Pharmaceuticals, Inc.
Issue:	Common stock
Amount:	$129 million
Shares:	3 million
Greenshoe:	450,000
Price:	$43.00
Bookrunners:	Goldman, Sachs & Co. and Morgan Stanley & Co. Inc.
Pricing date:	Nov. 15, after close
Stock symbol:	Nasdaq: ALXN
Stock price:	$43.35 at close Nov. 15

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.